• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

"自发性"药物相关性下颌骨坏死;两例报告和系统评价。

"Spontaneous" medication-related osteonecrosis of the jaw; two case reports and a systematic review.

机构信息

Dental Unit, The Alfred Hospital, Prahran, Victoria, Australia.

Melbourne Dental School, Royal Dental Hospital of Melbourne, Carlton, Victoria, Australia.

出版信息

Aust Dent J. 2018 Dec;63(4):441-454. doi: 10.1111/adj.12648. Epub 2018 Sep 9.

DOI:10.1111/adj.12648
PMID:30144095
Abstract

Medication-related osteonecrosis of the jaw (MRONJ) is a severe adverse drug effect consisting of bone destruction of the maxilla and/or mandible. The most common precipitating event described in the literature is the extraction of a tooth followed by "spontaneous" occurrence with no clear predisposing event. Current studies are investigating methods of managing dental extractions in patients at risk of MRONJ; however, no studies to date examine the aetiology and management of "spontaneous" MRONJ. This paper describes two cases of "spontaneous" MRONJ seen at the Dental Unit in the Alfred Hospital and systematically reviews the current literature. No significant interactions (P > 0.05) were detected between variables: age, sex, bone disease, antiresorptive, antiresorptive duration, jaw, location and stage. "Spontaneous" cases were commonly associated with the mylohyoid ridge, palatal tori and other anatomical sites, and tended to occur in those generally considered at low risk of developing MRONJ. The review suggests that perhaps the term "spontaneous" is a misnomer and thorough history taking is critical in establishing a precipitating event.

摘要

药物相关性颌骨坏死(MRONJ)是一种严重的药物不良反应,表现为上颌骨和/或下颌骨的骨破坏。文献中描述的最常见的诱发事件是拔牙后“自发性”发生,没有明确的诱发事件。目前的研究正在探讨在有 MRONJ 风险的患者中管理拔牙的方法;然而,迄今为止,尚无研究探讨“自发性”MRONJ 的病因和治疗。本文描述了在阿尔弗雷德医院牙科病房中发现的两例“自发性”MRONJ 病例,并对当前文献进行了系统回顾。未检测到变量之间存在显著相互作用(P>0.05):年龄、性别、骨疾病、抗吸收剂、抗吸收剂持续时间、颌骨、位置和阶段。“自发性”病例通常与下颌舌骨嵴、腭结节和其他解剖部位有关,并且往往发生在那些通常被认为发生 MRONJ 风险较低的人群中。综述表明,“自发性”这个术语可能是用词不当,彻底的病史采集对于确定诱发事件至关重要。

相似文献

1
"Spontaneous" medication-related osteonecrosis of the jaw; two case reports and a systematic review."自发性"药物相关性下颌骨坏死;两例报告和系统评价。
Aust Dent J. 2018 Dec;63(4):441-454. doi: 10.1111/adj.12648. Epub 2018 Sep 9.
2
Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.药物相关性颌骨坏死:双膦酸盐治疗患者与抗吸收-抗血管生成药物治疗患者的风险因素
Minerva Stomatol. 2017 Aug;66(4):135-140. doi: 10.23736/S0026-4970.17.04056-0. Epub 2017 May 10.
3
Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?影响接受大剂量双膦酸盐或地舒单抗治疗的癌症患者药物相关性颌骨坏死发展的因素:拔牙是否为危险因素?
PLoS One. 2018 Jul 26;13(7):e0201343. doi: 10.1371/journal.pone.0201343. eCollection 2018.
4
What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A systematic review.抗吸收药物 (ARDs) 对骨质疏松症患者药物相关性颌骨坏死 (MRONJ) 发展的影响:系统评价。
J Craniomaxillofac Surg. 2017 Sep;45(9):1493-1502. doi: 10.1016/j.jcms.2017.05.028. Epub 2017 Jun 3.
5
Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention.药物相关性颌骨坏死:纪念斯隆凯特琳癌症中心经验及预防中预防性牙科评估作用的最新进展
Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 May;125(5):440-445. doi: 10.1016/j.oooo.2018.02.003. Epub 2018 Feb 14.
6
The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.药物性颌骨坏死的发生率及其相关危险因素。
Oral Maxillofac Surg Clin North Am. 2015 Nov;27(4):509-16. doi: 10.1016/j.coms.2015.06.003. Epub 2015 Sep 9.
7
Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw.药物相关性颌骨坏死的诊断与分期
Oral Maxillofac Surg Clin North Am. 2015 Nov;27(4):479-87. doi: 10.1016/j.coms.2015.06.008. Epub 2015 Aug 18.
8
Antiresorptive drug-related osteonecrosis of the jaw.抗吸收药物相关的颌骨坏死
Dent Clin North Am. 2014 Apr;58(2):369-84. doi: 10.1016/j.cden.2013.12.006.
9
A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?一项多中心回顾性研究,探讨了接受口服双膦酸盐治疗的拔牙后药物相关性颌骨坏死的相关风险因素:原发伤口闭合和药物暂停真的能预防 MRONJ 吗?
Osteoporos Int. 2017 Aug;28(8):2465-2473. doi: 10.1007/s00198-017-4063-7. Epub 2017 Apr 27.
10
Rodents as an animal model for studying tooth extraction-related medication-related osteonecrosis of the jaw: assessment of outcomes.啮齿动物作为研究拔牙相关药物性颌骨坏死的动物模型:结局评估。
Arch Oral Biol. 2024 Mar;159:105875. doi: 10.1016/j.archoralbio.2023.105875. Epub 2023 Dec 26.

引用本文的文献

1
Endodontic therapy and Medication-related osteonecrosis of the jaw onset: a scoping review and expert opinion-based qualitative meta-synthesis.牙髓治疗与颌骨药物性骨坏死的发病:一项范围综述和基于专家意见的定性元分析。
BMC Oral Health. 2025 Aug 23;25(1):1362. doi: 10.1186/s12903-025-06741-5.
2
Potential role of comprehensive dental care in preventing medication related osteonecrosis of the jaw (MRONJ): a single centre study.综合口腔护理在预防药物相关性颌骨坏死(MRONJ)中的潜在作用:单中心研究。
BMC Oral Health. 2024 Oct 26;24(1):1291. doi: 10.1186/s12903-024-05081-0.
3
Medication-Related Osteonecrosis of the Jaw: A Systematic Review of Case Reports and Case Series.
药物相关性颌骨坏死:病例报告与病例系列的系统评价
Diseases. 2024 Sep 9;12(9):205. doi: 10.3390/diseases12090205.
4
Geranylgeraniol (GGOH), incorporated into a bone cement pellet promotes osteoclast function and healing in a model of medication-related osteonecrosis of the jaw.香叶基香叶醇(GGOH)掺入骨水泥微丸中,可促进颌骨药物相关性骨坏死模型中的破骨细胞功能和愈合。
J Oral Biol Craniofac Res. 2024 Mar-Apr;14(2):126-132. doi: 10.1016/j.jobcr.2024.01.014. Epub 2024 Feb 1.
5
Dental Management of Medication-Related OSTEONECROSIS of the JAW: WHILE RARE, THIS PATHOLOGY HAS DEVASTATING EFFECTS ON PATIENT HEALTH AND QUALITY OF LIFE.药物相关性颌骨坏死的牙科管理:虽然罕见,但这种病理状况对患者健康和生活质量具有毁灭性影响。
Decis Dent. 2023 Sep;9(8):28-31. Epub 2023 Sep 11.
6
Prevention and management of drug-induced osteonecrosis of the jaws using platelet-rich fibrin: A clinical feasibility study.应用富血小板纤维蛋白预防和治疗药物性下颌骨坏死:一项临床可行性研究。
Clin Exp Dent Res. 2023 Oct;9(5):791-798. doi: 10.1002/cre2.775. Epub 2023 Aug 21.
7
Associated systemic diseases and etiologies of medication-related osteonecrosis of the jaw: a retrospective study of 265 surgical cases.颌骨药物相关性骨坏死的相关全身性疾病及病因:265例手术病例的回顾性研究
Maxillofac Plast Reconstr Surg. 2023 Feb 28;45(1):12. doi: 10.1186/s40902-023-00377-7.
8
Post-COVID-19 related osteonecrosis of the jaw (PC-RONJ): an alarming morbidity in COVID-19 surviving patients.COVID-19 相关颌骨坏死(PC-RONJ):COVID-19 幸存患者中令人震惊的发病率。
BMC Infect Dis. 2022 Jun 14;22(1):544. doi: 10.1186/s12879-022-07518-9.
9
A 5-year retrospective cohort study of denosumab induced medication related osteonecrosis of the jaw in osteoporosis patients.一项针对骨质疏松症患者接受地舒单抗治疗导致的药物相关性颌骨坏死的 5 年回顾性队列研究。
Sci Rep. 2022 May 23;12(1):8641. doi: 10.1038/s41598-022-11615-9.
10
A Review Into the Effects of Pamidronic Acid and Zoledronic Acid on the Oral Mucosa in Medication-Related Osteonecrosis of the Jaw.帕米膦酸和唑来膦酸对颌骨药物相关性骨坏死口腔黏膜影响的综述
Front Oral Health. 2022 Feb 9;2:822411. doi: 10.3389/froh.2021.822411. eCollection 2021.